The global market for Transmucosal Drug Delivery Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Transmucosal drug delivery devices are commonly used to deliver drugs locally through the mucous membrane.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Transmucosal Drug Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transmucosal Drug Delivery Devices.

The Transmucosal Drug Delivery Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transmucosal Drug Delivery Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Transmucosal Drug Delivery Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Transmucosal Drug Delivery Devices Market Report

Report Metric	Details
Report Name	Transmucosal Drug Delivery Devices Market
CAGR	5%
Segment by Type	Buccal Route Rectal Route Nasal Route
Segment by Application	Hospital Residential
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Allergan, Amphastar Pharmaceuticals Inc, Aquestive Therapeutics Inc, ARS Pharmaceuticals, Combinent BioMedical Systems Inc, Aegis Therapeutics LLC, Bespak Europe Ltd, Callitas Therapeutics Inc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Transmucosal Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Transmucosal Drug Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Transmucosal Drug Delivery Devices Market report?

Ans: The main players in the Transmucosal Drug Delivery Devices Market are Allergan, Amphastar Pharmaceuticals Inc, Aquestive Therapeutics Inc, ARS Pharmaceuticals, Combinent BioMedical Systems Inc, Aegis Therapeutics LLC, Bespak Europe Ltd, Callitas Therapeutics Inc

What are the Application segmentation covered in the Transmucosal Drug Delivery Devices Market report?

Ans: The Applications covered in the Transmucosal Drug Delivery Devices Market report are Hospital, Residential

What are the Type segmentation covered in the Transmucosal Drug Delivery Devices Market report?

Ans: The Types covered in the Transmucosal Drug Delivery Devices Market report are Buccal Route, Rectal Route, Nasal Route

1 Transmucosal Drug Delivery Devices Market Overview

1.1 Product Definition

1.2 Transmucosal Drug Delivery Devices by Type

1.2.1 Global Transmucosal Drug Delivery Devices Market Value Comparison by Type (2024 VS 2031)

1.2.2 Buccal Route

1.2.3 Rectal Route

1.2.4 Nasal Route

1.3 Transmucosal Drug Delivery Devices by Application

1.3.1 Global Transmucosal Drug Delivery Devices Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Residential

1.4 Global Transmucosal Drug Delivery Devices Market Size Estimates and Forecasts

1.4.1 Global Transmucosal Drug Delivery Devices Revenue 2020-2031

1.4.2 Global Transmucosal Drug Delivery Devices Sales 2020-2031

1.4.3 Global Transmucosal Drug Delivery Devices Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Transmucosal Drug Delivery Devices Market Competition by Manufacturers

2.1 Global Transmucosal Drug Delivery Devices Sales Market Share by Manufacturers (2020-2025)

2.2 Global Transmucosal Drug Delivery Devices Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Transmucosal Drug Delivery Devices Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Transmucosal Drug Delivery Devices, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Transmucosal Drug Delivery Devices, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Transmucosal Drug Delivery Devices, Product Type & Application

2.7 Global Key Manufacturers of Transmucosal Drug Delivery Devices, Date of Enter into This Industry

2.8 Global Transmucosal Drug Delivery Devices Market Competitive Situation and Trends

2.8.1 Global Transmucosal Drug Delivery Devices Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Transmucosal Drug Delivery Devices Players Market Share by Revenue

2.8.3 Global Transmucosal Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Transmucosal Drug Delivery Devices Market Scenario by Region

3.1 Global Transmucosal Drug Delivery Devices Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Transmucosal Drug Delivery Devices Sales by Region: 2020-2031

3.2.1 Global Transmucosal Drug Delivery Devices Sales by Region: 2020-2025

3.2.2 Global Transmucosal Drug Delivery Devices Sales by Region: 2026-2031

3.3 Global Transmucosal Drug Delivery Devices Revenue by Region: 2020-2031

3.3.1 Global Transmucosal Drug Delivery Devices Revenue by Region: 2020-2025

3.3.2 Global Transmucosal Drug Delivery Devices Revenue by Region: 2026-2031

3.4 North America Transmucosal Drug Delivery Devices Market Facts & Figures by Country

3.4.1 North America Transmucosal Drug Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Transmucosal Drug Delivery Devices Sales by Country (2020-2031)

3.4.3 North America Transmucosal Drug Delivery Devices Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Transmucosal Drug Delivery Devices Market Facts & Figures by Country

3.5.1 Europe Transmucosal Drug Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Transmucosal Drug Delivery Devices Sales by Country (2020-2031)

3.5.3 Europe Transmucosal Drug Delivery Devices Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Transmucosal Drug Delivery Devices Market Facts & Figures by Region

3.6.1 Asia Pacific Transmucosal Drug Delivery Devices Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Transmucosal Drug Delivery Devices Sales by Region (2020-2031)

3.6.3 Asia Pacific Transmucosal Drug Delivery Devices Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Transmucosal Drug Delivery Devices Market Facts & Figures by Country

3.7.1 Latin America Transmucosal Drug Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Transmucosal Drug Delivery Devices Sales by Country (2020-2031)

3.7.3 Latin America Transmucosal Drug Delivery Devices Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Transmucosal Drug Delivery Devices Market Facts & Figures by Country

3.8.1 Middle East and Africa Transmucosal Drug Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Transmucosal Drug Delivery Devices Sales by Country (2020-2031)

3.8.3 Middle East and Africa Transmucosal Drug Delivery Devices Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Transmucosal Drug Delivery Devices Sales by Type (2020-2031)

4.1.1 Global Transmucosal Drug Delivery Devices Sales by Type (2020-2025)

4.1.2 Global Transmucosal Drug Delivery Devices Sales by Type (2026-2031)

4.1.3 Global Transmucosal Drug Delivery Devices Sales Market Share by Type (2020-2031)

4.2 Global Transmucosal Drug Delivery Devices Revenue by Type (2020-2031)

4.2.1 Global Transmucosal Drug Delivery Devices Revenue by Type (2020-2025)

4.2.2 Global Transmucosal Drug Delivery Devices Revenue by Type (2026-2031)

4.2.3 Global Transmucosal Drug Delivery Devices Revenue Market Share by Type (2020-2031)

4.3 Global Transmucosal Drug Delivery Devices Price by Type (2020-2031)

5 Segment by Application

5.1 Global Transmucosal Drug Delivery Devices Sales by Application (2020-2031)

5.1.1 Global Transmucosal Drug Delivery Devices Sales by Application (2020-2025)

5.1.2 Global Transmucosal Drug Delivery Devices Sales by Application (2026-2031)

5.1.3 Global Transmucosal Drug Delivery Devices Sales Market Share by Application (2020-2031)

5.2 Global Transmucosal Drug Delivery Devices Revenue by Application (2020-2031)

5.2.1 Global Transmucosal Drug Delivery Devices Revenue by Application (2020-2025)

5.2.2 Global Transmucosal Drug Delivery Devices Revenue by Application (2026-2031)

5.2.3 Global Transmucosal Drug Delivery Devices Revenue Market Share by Application (2020-2031)

5.3 Global Transmucosal Drug Delivery Devices Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Allergan

6.1.1 Allergan Company Information

6.1.2 Allergan Description and Business Overview

6.1.3 Allergan Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Allergan Transmucosal Drug Delivery Devices Product Portfolio

6.1.5 Allergan Recent Developments/Updates

6.2 Amphastar Pharmaceuticals Inc

6.2.1 Amphastar Pharmaceuticals Inc Company Information

6.2.2 Amphastar Pharmaceuticals Inc Description and Business Overview

6.2.3 Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Product Portfolio

6.2.5 Amphastar Pharmaceuticals Inc Recent Developments/Updates

6.3 Aquestive Therapeutics Inc

6.3.1 Aquestive Therapeutics Inc Company Information

6.3.2 Aquestive Therapeutics Inc Description and Business Overview

6.3.3 Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Product Portfolio

6.3.5 Aquestive Therapeutics Inc Recent Developments/Updates

6.4 ARS Pharmaceuticals

6.4.1 ARS Pharmaceuticals Company Information

6.4.2 ARS Pharmaceuticals Description and Business Overview

6.4.3 ARS Pharmaceuticals Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.4.4 ARS Pharmaceuticals Transmucosal Drug Delivery Devices Product Portfolio

6.4.5 ARS Pharmaceuticals Recent Developments/Updates

6.5 Combinent BioMedical Systems Inc

6.5.1 Combinent BioMedical Systems Inc Company Information

6.5.2 Combinent BioMedical Systems Inc Description and Business Overview

6.5.3 Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Product Portfolio

6.5.5 Combinent BioMedical Systems Inc Recent Developments/Updates

6.6 Aegis Therapeutics LLC

6.6.1 Aegis Therapeutics LLC Company Information

6.6.2 Aegis Therapeutics LLC Description and Business Overview

6.6.3 Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Product Portfolio

6.6.5 Aegis Therapeutics LLC Recent Developments/Updates

6.7 Bespak Europe Ltd

6.7.1 Bespak Europe Ltd Company Information

6.7.2 Bespak Europe Ltd Description and Business Overview

6.7.3 Bespak Europe Ltd Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Bespak Europe Ltd Transmucosal Drug Delivery Devices Product Portfolio

6.7.5 Bespak Europe Ltd Recent Developments/Updates

6.8 Callitas Therapeutics Inc

6.8.1 Callitas Therapeutics Inc Company Information

6.8.2 Callitas Therapeutics Inc Description and Business Overview

6.8.3 Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Product Portfolio

6.8.5 Callitas Therapeutics Inc Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Transmucosal Drug Delivery Devices Industry Chain Analysis

7.2 Transmucosal Drug Delivery Devices Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Transmucosal Drug Delivery Devices Production Mode & Process Analysis

7.4 Transmucosal Drug Delivery Devices Sales and Marketing

7.4.1 Transmucosal Drug Delivery Devices Sales Channels

7.4.2 Transmucosal Drug Delivery Devices Distributors

7.5 Transmucosal Drug Delivery Devices Customer Analysis

8 Transmucosal Drug Delivery Devices Market Dynamics

8.1 Transmucosal Drug Delivery Devices Industry Trends

8.2 Transmucosal Drug Delivery Devices Market Drivers

8.3 Transmucosal Drug Delivery Devices Market Challenges

8.4 Transmucosal Drug Delivery Devices Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Allergan plc

Amphastar Pharmaceuticals Inc

Aquestive Therapeutics Inc

ARS Pharmaceuticals

Combinent BioMedical Systems Inc

Aegis Therapeutics LLC

Bespak Europe Ltd

Callitas Therapeutics Inc

List of Tables

Table 1. Global Transmucosal Drug Delivery Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Transmucosal Drug Delivery Devices Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Transmucosal Drug Delivery Devices Market Competitive Situation by Manufacturers in 2024

Table 4. Global Transmucosal Drug Delivery Devices Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Transmucosal Drug Delivery Devices Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Transmucosal Drug Delivery Devices Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Transmucosal Drug Delivery Devices Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Transmucosal Drug Delivery Devices Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Transmucosal Drug Delivery Devices, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Transmucosal Drug Delivery Devices, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Transmucosal Drug Delivery Devices, Product Type & Application

Table 12. Global Key Manufacturers of Transmucosal Drug Delivery Devices, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Transmucosal Drug Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transmucosal Drug Delivery Devices as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Transmucosal Drug Delivery Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Transmucosal Drug Delivery Devices Sales by Region (2020-2025) & (K Units)

Table 18. Global Transmucosal Drug Delivery Devices Sales Market Share by Region (2020-2025)

Table 19. Global Transmucosal Drug Delivery Devices Sales by Region (2026-2031) & (K Units)

Table 20. Global Transmucosal Drug Delivery Devices Sales Market Share by Region (2026-2031)

Table 21. Global Transmucosal Drug Delivery Devices Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Transmucosal Drug Delivery Devices Revenue Market Share by Region (2020-2025)

Table 23. Global Transmucosal Drug Delivery Devices Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Transmucosal Drug Delivery Devices Revenue Market Share by Region (2026-2031)

Table 25. North America Transmucosal Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Transmucosal Drug Delivery Devices Sales by Country (2020-2025) & (K Units)

Table 27. North America Transmucosal Drug Delivery Devices Sales by Country (2026-2031) & (K Units)

Table 28. North America Transmucosal Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Transmucosal Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Transmucosal Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Transmucosal Drug Delivery Devices Sales by Country (2020-2025) & (K Units)

Table 32. Europe Transmucosal Drug Delivery Devices Sales by Country (2026-2031) & (K Units)

Table 33. Europe Transmucosal Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Transmucosal Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Transmucosal Drug Delivery Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Transmucosal Drug Delivery Devices Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Transmucosal Drug Delivery Devices Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Transmucosal Drug Delivery Devices Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Transmucosal Drug Delivery Devices Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Transmucosal Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Transmucosal Drug Delivery Devices Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Transmucosal Drug Delivery Devices Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Transmucosal Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Transmucosal Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Transmucosal Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Transmucosal Drug Delivery Devices Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Transmucosal Drug Delivery Devices Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Transmucosal Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Transmucosal Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Transmucosal Drug Delivery Devices Sales (K Units) by Type (2020-2025)

Table 51. Global Transmucosal Drug Delivery Devices Sales (K Units) by Type (2026-2031)

Table 52. Global Transmucosal Drug Delivery Devices Sales Market Share by Type (2020-2025)

Table 53. Global Transmucosal Drug Delivery Devices Sales Market Share by Type (2026-2031)

Table 54. Global Transmucosal Drug Delivery Devices Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Transmucosal Drug Delivery Devices Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Transmucosal Drug Delivery Devices Revenue Market Share by Type (2020-2025)

Table 57. Global Transmucosal Drug Delivery Devices Revenue Market Share by Type (2026-2031)

Table 58. Global Transmucosal Drug Delivery Devices Price (USD/Unit) by Type (2020-2025)

Table 59. Global Transmucosal Drug Delivery Devices Price (USD/Unit) by Type (2026-2031)

Table 60. Global Transmucosal Drug Delivery Devices Sales (K Units) by Application (2020-2025)

Table 61. Global Transmucosal Drug Delivery Devices Sales (K Units) by Application (2026-2031)

Table 62. Global Transmucosal Drug Delivery Devices Sales Market Share by Application (2020-2025)

Table 63. Global Transmucosal Drug Delivery Devices Sales Market Share by Application (2026-2031)

Table 64. Global Transmucosal Drug Delivery Devices Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Transmucosal Drug Delivery Devices Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Transmucosal Drug Delivery Devices Revenue Market Share by Application (2020-2025)

Table 67. Global Transmucosal Drug Delivery Devices Revenue Market Share by Application (2026-2031)

Table 68. Global Transmucosal Drug Delivery Devices Price (USD/Unit) by Application (2020-2025)

Table 69. Global Transmucosal Drug Delivery Devices Price (USD/Unit) by Application (2026-2031)

Table 70. Allergan Company Information

Table 71. Allergan Description and Business Overview

Table 72. Allergan Transmucosal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Allergan Transmucosal Drug Delivery Devices Product

Table 74. Allergan Recent Developments/Updates

Table 75. Amphastar Pharmaceuticals Inc Company Information

Table 76. Amphastar Pharmaceuticals Inc Description and Business Overview

Table 77. Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Product

Table 79. Amphastar Pharmaceuticals Inc Recent Developments/Updates

Table 80. Aquestive Therapeutics Inc Company Information

Table 81. Aquestive Therapeutics Inc Description and Business Overview

Table 82. Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Product

Table 84. Aquestive Therapeutics Inc Recent Developments/Updates

Table 85. ARS Pharmaceuticals Company Information

Table 86. ARS Pharmaceuticals Description and Business Overview

Table 87. ARS Pharmaceuticals Transmucosal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. ARS Pharmaceuticals Transmucosal Drug Delivery Devices Product

Table 89. ARS Pharmaceuticals Recent Developments/Updates

Table 90. Combinent BioMedical Systems Inc Company Information

Table 91. Combinent BioMedical Systems Inc Description and Business Overview

Table 92. Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Product

Table 94. Combinent BioMedical Systems Inc Recent Developments/Updates

Table 95. Aegis Therapeutics LLC Company Information

Table 96. Aegis Therapeutics LLC Description and Business Overview

Table 97. Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Product

Table 99. Aegis Therapeutics LLC Recent Developments/Updates

Table 100. Bespak Europe Ltd Company Information

Table 101. Bespak Europe Ltd Description and Business Overview

Table 102. Bespak Europe Ltd Transmucosal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Bespak Europe Ltd Transmucosal Drug Delivery Devices Product

Table 104. Bespak Europe Ltd Recent Developments/Updates

Table 105. Callitas Therapeutics Inc Company Information

Table 106. Callitas Therapeutics Inc Description and Business Overview

Table 107. Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Product

Table 109. Callitas Therapeutics Inc Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Transmucosal Drug Delivery Devices Distributors List

Table 113. Transmucosal Drug Delivery Devices Customers List

Table 114. Transmucosal Drug Delivery Devices Market Trends

Table 115. Transmucosal Drug Delivery Devices Market Drivers

Table 116. Transmucosal Drug Delivery Devices Market Challenges

Table 117. Transmucosal Drug Delivery Devices Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Product Picture of Transmucosal Drug Delivery Devices

Figure 2. Global Transmucosal Drug Delivery Devices Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Transmucosal Drug Delivery Devices Market Share by Type: 2024 & 2031

Figure 4. Buccal Route Product Picture

Figure 5. Rectal Route Product Picture

Figure 6. Nasal Route Product Picture

Figure 7. Global Transmucosal Drug Delivery Devices Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Transmucosal Drug Delivery Devices Market Share by Application: 2024 & 2031

Figure 9. Hospital

Figure 10. Residential

Figure 11. Global Transmucosal Drug Delivery Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Transmucosal Drug Delivery Devices Market Size (2020-2031) & (US$ Million)

Figure 13. Global Transmucosal Drug Delivery Devices Sales (2020-2031) & (K Units)

Figure 14. Global Transmucosal Drug Delivery Devices Average Price (USD/Unit) & (2020-2031)

Figure 15. Transmucosal Drug Delivery Devices Report Years Considered

Figure 16. Transmucosal Drug Delivery Devices Sales Share by Manufacturers in 2024

Figure 17. Global Transmucosal Drug Delivery Devices Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Transmucosal Drug Delivery Devices Players: Market Share by Revenue in Transmucosal Drug Delivery Devices in 2024

Figure 19. Transmucosal Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Transmucosal Drug Delivery Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Transmucosal Drug Delivery Devices Sales Market Share by Country (2020-2031)

Figure 22. North America Transmucosal Drug Delivery Devices Revenue Market Share by Country (2020-2031)

Figure 23. U.S. Transmucosal Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Transmucosal Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Transmucosal Drug Delivery Devices Sales Market Share by Country (2020-2031)

Figure 26. Europe Transmucosal Drug Delivery Devices Revenue Market Share by Country (2020-2031)

Figure 27. Germany Transmucosal Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Transmucosal Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Transmucosal Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Transmucosal Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Transmucosal Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Transmucosal Drug Delivery Devices Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Transmucosal Drug Delivery Devices Revenue Market Share by Region (2020-2031)

Figure 34. China Transmucosal Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Transmucosal Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Transmucosal Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Transmucosal Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Transmucosal Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Taiwan Transmucosal Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Transmucosal Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Transmucosal Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Transmucosal Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Philippines Transmucosal Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Transmucosal Drug Delivery Devices Sales Market Share by Country (2020-2031)

Figure 45. Latin America Transmucosal Drug Delivery Devices Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Transmucosal Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Transmucosal Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Transmucosal Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Transmucosal Drug Delivery Devices Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Transmucosal Drug Delivery Devices Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Transmucosal Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Transmucosal Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. U.A.E Transmucosal Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Transmucosal Drug Delivery Devices by Type (2020-2031)

Figure 55. Global Revenue Market Share of Transmucosal Drug Delivery Devices by Type (2020-2031)

Figure 56. Global Transmucosal Drug Delivery Devices Price (USD/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of Transmucosal Drug Delivery Devices by Application (2020-2031)

Figure 58. Global Revenue Market Share of Transmucosal Drug Delivery Devices by Application (2020-2031)

Figure 59. Global Transmucosal Drug Delivery Devices Price (USD/Unit) by Application (2020-2031)

Figure 60. Transmucosal Drug Delivery Devices Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Transmucosal Drug Delivery Systems Market Insights Forecast to 2030

Oral Transmucosal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gastrointestinal Device Market Research Report 2025

Global Nasal Drug Delivery Devices Market Research Report 2024

Global Transdermal Transmucosal Drug Delivery System Market Insights Forecast to 2030

Global Transcatheter Valve Delivery Devices Pipeline Market Research Report 2024

Global Transvaginal Mesh Device Market Research Report 2025

Global Trans Jejunal Feeding Tube Market Research Report 2025

Global Intravenous Drug Delivery Devices Market Research Report 2025

Global Gastrointestinal GI Devices Market Research Report 2025

Medical Implantable Drug Delivery Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Subcutaneous Drug Delivery Devices Market Insights Forecast to 2030

Global Multiparticulate Drug Delivery System Market Research Report 2024

Global Transcatheter Intervention Devices Market Research Report 2024

Nasal Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Transtympanic Delivery System Market Research Report 2024

Gastrointestinal Endoscopy Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Submucosal Injection Solution Market Research Report 2025

Global Intranasal Mucosal Atomization Device Market Research Report 2025

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions